Breaking News Instant updates and real-time market news.

HSDT

Helius Medical

$6.82

-0.15 (-2.15%)

16:22
03/05/19
03/05
16:22
03/05/19
16:22

Helius Medical initiated with an Outperform at Oppenheimer

Oppenheimer analyst Steven Lichtman started Helius Medical with an Outperform rating and $10 price target. While FDA approval of the company's Portable Neuromodulation Stimulator device is still pending and market development work remains, the "opportunity ahead is significant," Lichtman tells investors in a research note. He points out that 2.1M people in the U.S. suffer from chronic symptoms of traumatic brain injury with a primary complication of balance or gait disability. The analyst sees 2019 as a key year for Helius as it awaits FDA approval and begins a rollout in Canada.

  • 14

    Mar

HSDT Helius Medical
$6.82

-0.15 (-2.15%)

06/19/18
BTIG
06/19/18
DOWNGRADE
BTIG
Neutral
Helius Medical downgraded to Neutral from Buy at BTIG
06/19/18
BTIG
06/19/18
DOWNGRADE
BTIG
Neutral
Helius Medical downgraded to Neutral at BTIG on delay in PNS clearance
As reported, BTIG analyst Sean Lavin downgraded Helius Medical to Neutral from Buy citing yesterday's announced delay in filing for the FDA clearance of its Portable Neuromodulation Stimulator investigational medical device in Q3 rather than Q2. The analyst notes that the delay raises the risk of the company running out of cash before clearance and may force it to raise more capital, putting the spotlight on the management's credibility. Lavin adds that given the rise in the stock price to his prior target of $14, a Neutral rating is "more appropriate".
11/20/18
BTIG
11/20/18
UPGRADE
BTIG
Buy
Helius Medical upgraded to Buy from Neutral at BTIG
11/20/18
BTIG
11/20/18
UPGRADE
Target $14
BTIG
Buy
Helius Medical upgraded to Buy from Neutral at BTIG
BTIG analyst Sean Lavin upgraded Helius Medical to Buy from Neutral with a price target of $14. The analyst notes that the company's recent $17.5M stock offering removing the overhang of capital need that was cited in his prior downgrade. Lavin adds that Helius Medical now has the funding to operate until at least the middle of 2019 and sees the stock price retreat from $13 in June to $8 as an opportune time to buy, particularly in light of the recent announcement of the Clinical Experience Programs being in the works at two prestigious U.S. neurorehab centers that validate PoNS therapy.

TODAY'S FREE FLY STORIES

AGN

Allergan

$153.41

-0.26 (-0.17%)

, SIEN

Sientra

$9.78

0.025 (0.26%)

16:10
03/21/19
03/21
16:10
03/21/19
16:10
Hot Stocks
FDA posts briefing documents for advisory panel on breast implants »

The Food and Drug…

AGN

Allergan

$153.41

-0.26 (-0.17%)

SIEN

Sientra

$9.78

0.025 (0.26%)

ESTA

Establishment Labs

$27.05

-0.85 (-3.05%)

JNJ

Johnson & Johnson

$138.15

0.92 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 16

    Apr

  • 25

    Apr

  • 18

    May

  • 28

    May

GME

GameStop

$10.52

0.04 (0.38%)

16:08
03/21/19
03/21
16:08
03/21/19
16:08
Hot Stocks
GameStop appoints George Sherman as CEO »

GameStop Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 16

    Apr

CNAT

Conatus

$2.88

-0.01 (-0.35%)

16:08
03/21/19
03/21
16:08
03/21/19
16:08
Hot Stocks
Conatus announces Phase 2b ENCORE-NF trial results »

Conatus announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNNA

Sienna Biopharmaceuticals

$2.82

0.05 (1.81%)

16:07
03/21/19
03/21
16:07
03/21/19
16:07
Hot Stocks
Sienna Biopharmaceuticals promotes Alexander Azoy to CFO »

Sienna Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELF

e.l.f. Beauty

$9.85

-0.01 (-0.10%)

16:06
03/21/19
03/21
16:06
03/21/19
16:06
Hot Stocks
e.l.f. Beauty names Mandy Fields new CFO »

e.l.f. Beauty announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$26.35

0.55 (2.13%)

16:05
03/21/19
03/21
16:05
03/21/19
16:05
Hot Stocks
PulteGroup names John Chadwick COO »

PulteGroup announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VREX

Varex Imaging

$34.18

0.22 (0.65%)

16:05
03/21/19
03/21
16:05
03/21/19
16:05
Hot Stocks
Varex Imaging acquiring Swedish linear array digital detector maker »

Varex Imaging has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 28

    Mar

GRTS

Gritstone Oncology

$11.25

-0.45 (-3.85%)

16:04
03/21/19
03/21
16:04
03/21/19
16:04
Hot Stocks
Gritstone Oncology announces first patient dosed with GRANITE-001 »

Gritstone Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$22.07

-0.07 (-0.32%)

, BHGE

Baker Hughes

$28.51

0.25 (0.88%)

16:04
03/21/19
03/21
16:04
03/21/19
16:04
Hot Stocks
Yext names George Murphy as SVP, Global Strategic Alliances »

Yext (YEXT) has appointed…

YEXT

Yext

$22.07

-0.07 (-0.32%)

BHGE

Baker Hughes

$28.51

0.25 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 28

    May

  • 19

    Mar

OXFD

Oxford Immunotec

$18.00

0.04 (0.22%)

, GE

General Electric

$10.29

0.08 (0.78%)

16:03
03/21/19
03/21
16:03
03/21/19
16:03
Hot Stocks
Oxford Immunotec appoints Matthew McLaughlin CFO »

Oxford Immunotec Global…

OXFD

Oxford Immunotec

$18.00

0.04 (0.22%)

GE

General Electric

$10.29

0.08 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 08

    May

ACGL

Arch Capital

$32.35

0.36 (1.13%)

16:02
03/21/19
03/21
16:02
03/21/19
16:02
Hot Stocks
Arch Capital names John Pasquesi chairman of the board »

Arch Capital Group Ltd.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOK

Nokia

$6.32

0.03 (0.48%)

16:01
03/21/19
03/21
16:01
03/21/19
16:01
Hot Stocks
Nokia reports internal investigation into compliance at Alcatel Lucent »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

BIIB

Biogen

$225.22

-95.25 (-29.72%)

15:59
03/21/19
03/21
15:59
03/21/19
15:59
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

CNC

Centene

$58.93

0.24 (0.41%)

15:55
03/21/19
03/21
15:55
03/21/19
15:55
Options
Centene put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 09

    May

  • 28

    May

NOK

Nokia

$6.30

0.005 (0.08%)

15:52
03/21/19
03/21
15:52
03/21/19
15:52
Periodicals
Finland to investigate Nokia-branded phones over data breach report,Reuters says »

Finland's data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

CAL

Caleres

$25.72

-0.11 (-0.43%)

15:34
03/21/19
03/21
15:34
03/21/19
15:34
Options
Caleres options imply 11.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

CURLF

Curaleaf Holdings

$0.00

(0.00%)

, CVS

CVS Health

$57.28

1.11 (1.98%)

15:28
03/21/19
03/21
15:28
03/21/19
15:28
Hot Stocks
Curaleaf Holdings spikes 22% after report of CBD products pact with CVS »

Shares of Curaleaf…

CURLF

Curaleaf Holdings

$0.00

(0.00%)

CVS

CVS Health

$57.28

1.11 (1.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

LYG

Lloyds Banking

$3.27

-0.115 (-3.40%)

15:27
03/21/19
03/21
15:27
03/21/19
15:27
Options
Puts lead calls 140:1 in Lloyds Banking as shares underperform sector »

Puts lead calls 140:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVZ

Invesco

$19.88

0.16 (0.81%)

15:21
03/21/19
03/21
15:21
03/21/19
15:21
Conference/Events
Invesco management to meet with Morgan Stanley »

Meeting to be held In New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 28

    Mar

BV

BrightView

$15.34

-0.23 (-1.48%)

15:20
03/21/19
03/21
15:20
03/21/19
15:20
Hot Stocks
BrightView under investigation for potential securities laws violations »

Thornton Law Firm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

XHB

SPDR Homebuilders

$38.38

0.82 (2.18%)

15:20
03/21/19
03/21
15:20
03/21/19
15:20
Options
Aggressive call buying in SPDR Homebuilders Fund as the sector sees strength »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:20
03/21/19
03/21
15:20
03/21/19
15:20
General news
Canada CPI preview »

Canada CPI preview:…

15:20
03/21/19
03/21
15:20
03/21/19
15:20
General news
Canada retail sales preview »

Canada retail sales…

DLAKY

Lufthansa

$0.00

(0.00%)

15:19
03/21/19
03/21
15:19
03/21/19
15:19
Conference/Events
Lufthansa management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

JEF

Jefferies Financial Group

$19.35

0.04 (0.21%)

15:19
03/21/19
03/21
15:19
03/21/19
15:19
Options
Jefferies Financial Group options imply 4.0% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.